ATE366937T1 - Krebs-assoziiertes protein - Google Patents

Krebs-assoziiertes protein

Info

Publication number
ATE366937T1
ATE366937T1 AT02730520T AT02730520T ATE366937T1 AT E366937 T1 ATE366937 T1 AT E366937T1 AT 02730520 T AT02730520 T AT 02730520T AT 02730520 T AT02730520 T AT 02730520T AT E366937 T1 ATE366937 T1 AT E366937T1
Authority
AT
Austria
Prior art keywords
cancer
protein
associated protein
breast cancer
immunospecific
Prior art date
Application number
AT02730520T
Other languages
English (en)
Inventor
Jonathan A Terrett
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Application granted granted Critical
Publication of ATE366937T1 publication Critical patent/ATE366937T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/812—Breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02730520T 2001-06-15 2002-06-14 Krebs-assoziiertes protein ATE366937T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0114644.8A GB0114644D0 (en) 2001-06-15 2001-06-15 Protein

Publications (1)

Publication Number Publication Date
ATE366937T1 true ATE366937T1 (de) 2007-08-15

Family

ID=9916679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02730520T ATE366937T1 (de) 2001-06-15 2002-06-14 Krebs-assoziiertes protein

Country Status (7)

Country Link
US (1) US20040166517A1 (de)
EP (1) EP1395829B1 (de)
AT (1) ATE366937T1 (de)
DE (1) DE60221123T2 (de)
ES (1) ES2290298T3 (de)
GB (1) GB0114644D0 (de)
WO (1) WO2002103362A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3824906A1 (de) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antikörperformulierungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11146790A (ja) * 1997-11-18 1999-06-02 Sumitomo Pharmaceut Co Ltd Ｄｔｄｓｔ遺伝子発現ベクター
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
JP2003527849A (ja) * 2000-03-22 2003-09-24 キュラゲン コーポレイション 新規ペプチド及びこれをコードする核酸
WO2001098318A1 (en) * 2000-06-22 2001-12-27 Genaissance Pharmaceuticals, Inc. Haplotypes of the slc26a2 gene
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
AU2002337657A1 (en) * 2001-07-25 2003-02-17 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer

Also Published As

Publication number Publication date
EP1395829B1 (de) 2007-07-11
WO2002103362A2 (en) 2002-12-27
US20040166517A1 (en) 2004-08-26
ES2290298T3 (es) 2008-02-16
EP1395829A2 (de) 2004-03-10
DE60221123T2 (de) 2008-03-20
WO2002103362A3 (en) 2003-10-30
GB0114644D0 (en) 2001-08-08
DE60221123D1 (de) 2007-08-23

Similar Documents

Publication Publication Date Title
WO2003083485A3 (en) Protein for use in hypoxia related conditions
WO2004009622A3 (en) Protein complexes of cellular networks underlying the development of cancer and other diseases
TR200200472T2 (tr) Anti-Erb B2 antikorları ile tedavi için dozajlar
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
BR0315157A (pt) Métodos de tratar doença de alzheimer empregando-se anticorpos direcionados contra peptìdeo beta amilóide e composições deste
DK0552296T3 (da) Monoklonale antistoffer fra mus
RU2599417C3 (ru) Моноклональные антитела человека к белку программируемой смерти 1 (pd-1) и способы лечения рака с использованием анти-pd-1-антител самостоятельно или в комбинации с другими иммунотерапевтическими средствами
TW200510528A (en) Polypeptide inducing apoptosis
EP1516185A4 (de) Darstellung monoklonaler antikörper und behandlung von tumoren, die met exprimieren und den hepatozytischen wachstumsfaktor binden
DE60321041D1 (de) Antikörper gegen krebsantigen tmeff2 und seine anwendungen
WO2003016471A3 (en) Periostin-based diagnostic assays
WO2002088750A3 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
WO2001062784A3 (en) Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
GB0324656D0 (en) A protein involved in ovarian cancer
GB0004576D0 (en) Proteins
ATE290881T1 (de) Verwendung von anti-ferritin antikörper bei der behandlung von bestimmten krebsarten
EA200600995A1 (ru) Молекулы, ингибирующие ангиогенез, и их применение в лечении и диагностике рака
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
DE60221123D1 (de) Krebs-assoziiertes protein
WO2003087840A3 (en) Protein involved in cancer
WO2002090991A3 (en) Proteins and genes for diagnosis and treatment of erbb2-related cancer
WO2003087841A3 (en) An ephrin-b receptor protein involved in carcinoma
ATE425991T1 (de) Bestimmung von bone-sialoprotein in kírperflussigkeiten fur onkologische fragestellungen
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
HUP0301085A2 (hu) Új peptid és alkalmazása szelektálási eljárásra

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties